Shintaro Kuroda

1.6k total citations
112 papers, 1.1k citations indexed

About

Shintaro Kuroda is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Shintaro Kuroda has authored 112 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Hepatology, 50 papers in Surgery and 39 papers in Oncology. Recurrent topics in Shintaro Kuroda's work include Hepatocellular Carcinoma Treatment and Prognosis (40 papers), Liver Disease Diagnosis and Treatment (27 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers). Shintaro Kuroda is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (40 papers), Liver Disease Diagnosis and Treatment (27 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers). Shintaro Kuroda collaborates with scholars based in Japan. Shintaro Kuroda's co-authors include Hideki Ohdan, Tsuyoshi Kobayashi, Hirotaka Tashiro, Hironobu Amano, Akihiko Oshita, Michinori Hamaoka, Yuichi Sato, Hiroyuki Tahara, Masahiro Ohira and Kentaro Ide and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Power Sources.

In The Last Decade

Shintaro Kuroda

99 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shintaro Kuroda Japan 19 530 371 337 308 187 112 1.1k
Hisashi Nakayama Japan 17 521 1.0× 428 1.2× 262 0.8× 307 1.0× 216 1.2× 76 948
Akihisa Ueno Japan 16 240 0.5× 185 0.5× 291 0.9× 177 0.6× 264 1.4× 51 1.2k
Satoshi Ogiso Japan 20 645 1.2× 706 1.9× 501 1.5× 196 0.6× 269 1.4× 111 1.3k
Linwei Wu China 19 344 0.6× 330 0.9× 130 0.4× 237 0.8× 88 0.5× 67 1.1k
Krijn P. van Lienden Netherlands 27 733 1.4× 856 2.3× 745 2.2× 568 1.8× 589 3.1× 78 2.2k
Ruhai Zou China 19 783 1.5× 358 1.0× 247 0.7× 380 1.2× 212 1.1× 45 1.3k
Natsuko Kawada Japan 19 155 0.3× 653 1.8× 454 1.3× 356 1.2× 498 2.7× 43 1.3k
Yuta Abe Japan 22 836 1.6× 974 2.6× 933 2.8× 380 1.2× 670 3.6× 139 2.2k
Shintaro Yamazaki Japan 18 501 0.9× 498 1.3× 277 0.8× 219 0.7× 186 1.0× 92 979
Shiu-Feng Huang Taiwan 20 147 0.3× 431 1.2× 339 1.0× 187 0.6× 292 1.6× 42 1.1k

Countries citing papers authored by Shintaro Kuroda

Since Specialization
Citations

This map shows the geographic impact of Shintaro Kuroda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shintaro Kuroda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shintaro Kuroda more than expected).

Fields of papers citing papers by Shintaro Kuroda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shintaro Kuroda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shintaro Kuroda. The network helps show where Shintaro Kuroda may publish in the future.

Co-authorship network of co-authors of Shintaro Kuroda

This figure shows the co-authorship network connecting the top 25 collaborators of Shintaro Kuroda. A scholar is included among the top collaborators of Shintaro Kuroda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shintaro Kuroda. Shintaro Kuroda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohira, Masahiro, Yuki Imaoka, Koki Sato, et al.. (2025). A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation. PLoS ONE. 20(1). e0313102–e0313102. 1 indexed citations
2.
Shimizu, Seiichi, Shintaro Kuroda, Ryosuke Nakano, et al.. (2025). Durvalumab induced immune-related agranulocytosis after conversion surgery in a patient with intrahepatic cholangiocarcinoma: a case report. Frontiers in Immunology. 16. 1610190–1610190.
3.
Ohira, Masahiro, Yuki Imaoka, Minoru Hattori, et al.. (2024). The steatosis‐associated fibrosis estimator score is a useful indicator of recurrence and survival after initial curative hepatectomy for hepatocellular carcinoma. Annals of Gastroenterological Surgery. 9(1). 178–187.
5.
Hashimoto, Masakazu, et al.. (2024). Mucinous Cystic Neoplasm of the Liver in a Teenager: A Case Report. Cureus. 16(7). e65728–e65728. 1 indexed citations
6.
Hamaoka, Michinori, Kenichi Oishi, Daisuke Takei, et al.. (2024). Sarcopenia’s Impact Defined by Grip Strength and Muscle Mass on Post-hepatectomy Outcomes: A Multicenter Analysis. In Vivo. 38(6). 2827–2835.
7.
Kobayashi, Tsuyoshi, Shintaro Kuroda, Koichi Oishi, et al.. (2024). Albumin–Butyrylcholinesterase as a Novel Prognostic Biomarker for Hepatocellular Carcinoma Post-hepatectomy: A Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology. Annals of Surgical Oncology. 32(3). 1973–1984. 1 indexed citations
8.
Ohira, Masahiro, Yuki Imaoka, Shintaro Kuroda, et al.. (2023). Impact of Abdominal Aortic Calcification on Chronic Kidney Disease After Liver Transplantation: A Retrospective Study. Transplantation Proceedings. 55(4). 956–960. 3 indexed citations
9.
Takei, Daisuke, et al.. (2023). Outcomes and Prognostic Analysis of Surgical Resection for Oligometastasis from Hepatocellular Carcinoma. Anticancer Research. 43(11). 5189–5196.
10.
Okada, Kenjiro, Tsuyoshi Kobayashi, Shintaro Kuroda, et al.. (2023). Prognostic impact of pre- and postoperative tumor markers in patients with intrahepatic cholangiocarcinoma. Surgery Today. 54(2). 177–185. 1 indexed citations
11.
Imaoka, Yuki, Masahiro Ohira, Koki Sato, et al.. (2023). Impact of a new liver immune status index among patients with hepatocellular carcinoma after initial hepatectomy. Annals of Gastroenterological Surgery. 7(6). 987–996. 5 indexed citations
13.
Ohira, Masahiro, Koki Sato, Yuki Imaoka, et al.. (2023). Arteriosclerosis Decreases Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression on Liver Natural Killer Cells in Living Donor Liver Transplantation. Transplantation Proceedings. 55(4). 906–912. 2 indexed citations
14.
Shimizu, Seiichi, Masahiro Ohira, Yuka Tanaka, et al.. (2022). Adoptive immunotherapy overcomes genetic susceptibility to bloodstream infections due to fc-gamma receptor polymorphisms after liver transplantation. American Journal of Transplantation. 22(10). 2392–2400. 3 indexed citations
15.
Nakano, Ryosuke, Masahiro Ohira, Tsuyoshi Kobayashi, et al.. (2018). Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution. Surgery. 164(2). 219–226. 18 indexed citations
16.
Nakano, Ryosuke, Masahiro Ohira, Tsuyoshi Kobayashi, et al.. (2018). Independent risk factors that predict bile leakage after hepatectomy for hepatocellular carcinoma: Cohort study. International Journal of Surgery. 57. 1–7. 9 indexed citations
17.
Imaoka, Yuki, Masahiro Ohira, Tsuyoshi Kobayashi, et al.. (2016). Elective laparoscopic deroofing to treat the spontaneous rupture of a large simple liver cyst: a case report. Surgical Case Reports. 2(1). 148–148. 7 indexed citations
18.
Fujikuni, Nobuaki, et al.. (2010). A Case of True Gastric Carcinosarcoma with Lymph Nodes Metastasis containing Sarcomatous Component. The Japanese Journal of Gastroenterological Surgery. 43(8). 809–814. 6 indexed citations
19.
Kuroda, Shintaro, et al.. (2006). A Case of Granulocyte-Colony Stimulating Factor Producing Multiple Gastric Carcinoma. The Japanese Journal of Gastroenterological Surgery. 39(4). 457–463. 5 indexed citations
20.
Kuroda, Shintaro, et al.. (1982). [A case of mastocytoma associated with disseminated intravascular coagulation (DIC)].. PubMed. 23(5). 762–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026